References
- Pharmacy Guild of Australia. Australians missing out on faster, more accessible care by underutilising their community pharmacist. Canberra: Pharmacy Guild of Australia; 2025. At: https://www.guild.org.au/news-events/news/2025/australians-missing-out-on-faster,-more-accessible-care-by-underutilising-their-community-pharmacist
- Muluk V, Cohn SL, Whinney C. Perioperative medication management. UpToDate. 2025.
- Douketis JD, Spyropoulos AC, Murad MH. Perioperative management of patients receiving anticoagulants. Chest. 2022;161(5):e247-e269.
- Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery (POISE-2). N Engl J Med. 2014;370:1494-1503.
- Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional NSAIDs increase the risk of atherothrombosis? BMJ. 2006;332:1302-1308.
- Australian Diabetes Society, Australian Diabetes Educators Association, Australian and New Zealand College of Anaesthetists, New Zealand Society for the Study of Diabetes. Alert update May 2023: risk of diabetic ketoacidosis with SGLT2 inhibitors in the peri-procedural period. 2023. At: https://www.diabetessociety.com.au/wp-content/uploads/2023/05/ADS-ADEA-ANZCA-NZSSD_DKA_SGLT2i_Alert_Ver-May-2023.pdf
- Shuford R, Miller-Ocuin JL. Hyperglycemia in the perioperative period. Clin Colon Rectal Surg. 2023;36(3):198-200.
- Australian Diabetes Society. Peri-operative diabetes management guidelines. 2022.
- Legrand M, Falcone J, Cholley B, et al. Continuation vs discontinuation of renin-angiotensin system inhibitors before major noncardiac surgery: the Stop-or-Not randomized clinical trial. JAMA. 2024;332(12):970-978.
- Ackland GL, Patel A, Abbott TEF, et al. Discontinuation vs continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial. Eur Heart J. 2024;45(13):1146-1155.
- Hollmann C, Fernandes NL, Biccard BM. A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery. Anesth Analg. 2018;127(3):678-687.
- Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine by patients undergoing surgery: a systematic review. Clin Med. 2013;13(4):388-394.
- Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208-216.
- Pharmaceutical Defence Limited. Practice alert: dosage administration aids. Brisbane: Pharmaceutical Defence Limited. At: https://pdl.org.au/practice_alert/dosage-administration-aids/


This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Sources: Australasian College of Pharmacy. Management of reflux: a guideline for pharmacists. Queensland Health. Queensland Community Pharmacy Gastro-oesophageal Reflux and Gastro-oesophageal Reflux Disease – Clinical Practice Guideline. NSW Health. NSW Pharmacist Practice Standards for gastro-oesophageal reflux and gastro-oesophageal reflux disease.[/caption]

Dr Ming S Soh PhD, BPharm (Hons)[/caption]






DR Amy Page (she/her) PhD, MClinPharm, GradDipBiostat, GCertHProfEd, GAICD, GStat, FSHPA, FPS is a consultant pharmacist, biostatistician, and the director of the Centre for Optimisation of Medicines at UWA’s School of Allied Health.[/caption]

Hui Wen Quek (she/her) BPharm(Hons), GradCertAppPharmPrac is a pharmacist and PhD candidate at the University of Western Australia (UWA).[/caption]


